Skip to main content

BioResearch Partner(TM) Expands Into Georgia

With three new research sites now active in Atlanta, Georgia, BioResearch Partner strengthens itself as a leader in clinical research.

MIAMI, FL AND ATLANTA, GA / ACCESS Newswire / January 22, 2026 / One of South Florida's most luminary clinical research site management organizations has expanded its clinical research footprint into the City of Atlanta, GA, strategically positioning BioResearch Partner across north, south, and east Atlanta, and extends access to diverse, high-growth communities and reinforcing BRP's role as a vanguard in national clinical site development.

Building on its proven success in South Florida, BioResearch Partner is bringing the same high quality clinical research, rapid trial activation, and unwavering regulatory compliance to Georgia, delivering a modern wave of access to healthcare resources and renewed hope to underserved communities.

"This expansion extends our Miami model of excellence in clinical trials to Georgia, a move that marks but another milestone in Bio Research's plans to bring the same compassion in care to populations that lack opportunity in clinical research." Says Keila Hoover, M.D. Chief Medical Officer of BioResearch Partner (BRP). Utilizing accelerated access cutting-edge therapies BRP hopes to empower those who otherwise would not have many options for treatment. Georgia's unique demographic profile, marked by high rates of diabetes, hypertension, obesity, and respiratory conditions, creates an opportunity for BioResearch Partner to extend its proven site management model while opening the door for clinical research sites nationwide to collaborate and grow under its expanding network.

About BioResearch Partner

BioResearch Partner (BRP) is a premier Site Management Organization (SMO) headquartered in Miami, Florida, operating a growing national network of 23 integrated clinical research sites. Founded in 2014 by Keila Hoover M.D., BRP is recognized for its rapid study activation, diverse patient enrollment, and exceptional regulatory precision. With advanced diagnostic infrastructure, centralized quality assurance, and a database exceeding 600,000 patients, BRP manages protocols across therapeutic areas including cardiology, dermatology, oncology, metabolic, vaccines and more, driving innovation, inclusion, and access to the future of medicine.

CONTACT:

Daniel Gonzalez
+17865233836
dgonzalez@curaad.com

SOURCE: BioResearch Partner



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  235.49
+1.15 (0.49%)
AAPL  245.66
-2.69 (-1.08%)
AMD  260.51
+6.78 (2.67%)
BAC  51.53
-0.92 (-1.75%)
GOOG  332.74
+1.90 (0.57%)
META  649.79
+2.16 (0.33%)
MSFT  454.45
+3.31 (0.73%)
NVDA  187.59
+2.75 (1.49%)
ORCL  173.46
-4.72 (-2.65%)
TSLA  445.26
-4.10 (-0.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.